FDA Investigating Reports Of COVID Relapses Following Use Of Pfizer’s Pill


Authors: Zachary Stieber  May 8, 2022 The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. […]

Post Covid-19 complications: Skin issues, joint pain becoming increasingly common, say experts


People should seek good rehabilitative care, exercise every day, maintain good posture, and follow a healthy diet to manage joint and muscle pain Authors: By: Lifestyle Desk | New Delhi | The list of post-Covid complications seems to be only increasing with doctors now saying that there has also been an increase in skin conditions like herpes, and joint […]

Children get long Covid, too, and it can show up in unexpected ways


Authors: Jen Christensen, Fri May 6, 2022 CNN November 10 is a day Kim Ford remembers too well. It was the day last year when her 9-year-old son, Jack, was scheduled to get his Covid-19 vaccine at the school clinic. They were excited that he’d finally have some protection, but on November 9, he had […]

Coronavirus wave this fall could infect 100 million, administration warns


Authors: Yasmeen Abutaleb, Joel Achenbach May 6, 2022 The Washington Post The Biden administration is warning the United States could see 100 million coronavirus infections and a potentially significant wave of deaths this fall and winter, driven by new omicron subvariants that have shown a remarkable ability to escape immunity. The projection, made Friday by […]

FDA limits use of J&J vaccine over rare blood clots


Authors:  PETER SULLIVAN – 05/05/22 THE HILL The Food and Drug Administration (FDA) on Thursday announced that it is limiting the authorization for the Johnson & Johnson COVID-19 to people who cannot or will not get other versions of the vaccine, citing the risk of rare blood clots.   The authorization for the J&J vaccine, also […]

Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalized cohort


Authors: AdamHampshireaDoris A.ChatfieldbAnne ManktelowMPhilbAmyJollyaWilliamTrenderaPeter J.HellyeraMartina DelGiovaneaVirginia F.J.NewcombebJoanne G. Outtrimb BenWarneb JunaidBhattid LindaPointond AnneElmere NyarieSitholebf JohnBradleybgh NathalieKingston lStephen J.Sawceri Edward T.Bullmorecdj…David K.Menonbck1 Volume 47, May 2022, 101417 Summary Background Preliminary evidence has highlighted a possible association between severe COVID-19 and persistent cognitive deficits. Further research is required to confirm this association, determine whether cognitive deficits relate to clinical […]

COVID-19: Omicron variant did not wipe out Delta, it could return


While the Delta virus wiped out the variants that preceded it, Omicron has not eliminated Delta, according to a new study from Israel’s Ben-Gurion University of the Negev. Authors:  JUDY SIEGEL-ITZKOVICH Published: MAY 2, 2022  Don’t throw away your unused face masks yet. COVID-19’s Omicron variants may burn themselves out in the next couple of months, and the Delta […]

COVID-19 infection could age brain by 20 years, lower IQ significantly


Authors: Chris Melore Study Finds May 3, 2022 A severe coronavirus infection could leave patients with the brain of a 70-year-old, lowering someone’s IQ by 10 points, according to a new study. Researchers from the University of Cambridge and Imperial College London found that COVID patients are dealing with levels of cognitive impairment which are […]

Pfizer-BioNTech Vaccine Much Weaker in Kids Against Omicron and More


Authors: Mark Terry Published: Mar 01, 2022  BIOSPACE Pfizer-BioNTech Vaccine Only 12% Effective Against Omicron in 5-11-Year-Olds  In a new study that is yet to be peer-reviewed, the New York State Department of Health found that the Pfizer–BioNTech vaccine was only about 12% effective for children ages 5 to 11 years against the Omicron variant. In that age group, it […]

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line


Current Issues In Molecular Biology Authors: Markus Aldén 1 , Francisko Olofsson Falla 1 , Daowei Yang 1 , Mohammad Barghouth 1 , Cheng Luan 1 , Magnus Rasmussen 2 and Yang De Marinis 1,* Abstract: Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer andBioNTech, showed reversible hepatic effects in animals that received […]